Featured Content
Effective Communication With Patients Is Critical for Improved Quality of Life, Lower Costs
Repeated active discussions with patients about distress, treatment options, and goals can both reduce costs and help to identify when aggressive treatment is no longer ...
CDK4/6 Inhibitors in Breast Cancer Treatment: Recent Research, Safety Profiles, Acquired Resistance, Next Steps
Breast tumors can become resistant to CDK 4/6 inhibitors, but improved understanding of the mechanisms of acquired resistance might point to additional treatment strategies.
Q&A With Dr Chao: Oncotype DX Breast Recurrence Score® and Breast DCIS Score™
CTA spoke with Calvin Chao, MD, about how the Oncotype DX® test is implemented, how results can guide treatment, its use globally, and the future ...
Liquid Biopsies for Circulating Tumor Cells: A New Prognostic Tool?
While liquid biopsies could prove successful in monitoring treatments, these tests might also find early-stage cancers that, left alone, would never progress.
Malware in Medicine: Prevention Is Key to Protection
The race against malware is much the same as a war between an infectious agent and a host: it's a battle between hackers and security ...More Features>>>
Video Series
-
The Phase 3 PlanB Trial
-
Continue to Work?
-
Drug Resistance to CDK4/6 Inhibitors
-
Comparing Ribociclib and Palbociclib
-
Ribociclib, Abemaciclib, and Palbociclib
-
The Potential of CDK4/6 Inhibitors
-
How Cyclin D Plays A Role
-
Role of Cell Cycle in Progression
-
2016 SABCS: Clinical Insights
-
2016 SABCS: Clinical Insights
-
HER2-positive Metastatic and TNBC
-
Frontline Treatments
-
Treatment-related Neuropathy
-
ER-positive, HER2-negative
-
Emerging Medicines
-
Triple-negative Breast Cancer
-
Insights from the Lab and Clinic
-
Trastuzumab Resistance
-
Biologic Role of HER2
-
Strategies in Management
-
Lapatinib-based Regimen
-
Overcoming Trastuzumab Resistance
-
New Anti-HER2 Agents
-
HER2-targeted Therapies
-
Lapatinib and the Neoadjuvant Tx
-
Predicting Response/Resistance
-
AC-THP vs. TCHP Treatment
Breast Cancer News
Similar Efficacy, Less Toxicity with Neoadjuvant Letrozole/Palbociclib Versus Chemo in Breast Cancer
September 08, 2017
Breast Cancer Resources
More Breast Cancer Information
beta-Carotene and Cancer
September 20, 2017
Data indicate that beta-Carotene should not be recommended as a cancer prevention agent due to lack of efficacy and potential harm among smokers or those exposed to asbestos.
Zinc and Cancer
September 15, 2017
This fact sheet is a review of study data about the relationship between zinc supplementation and cancer incidence and outcomes.
Magnesium and Cancer
August 24, 2017
About 60% of Americans are deficient in magnesium, including up to 60% of patients who are critically ill.
Calcium and Cancer
August 18, 2017
Evidence is mixed about the relationship between calcium intake and colorectal/prostate cancers.
Aspartame and Cancer
August 15, 2017
Despite controversy, many studies have found no significant association between aspartame consumption and the incidence of different types of solid and hematologic malignancies.
The Treatment Landscape of Breast Cancer
The treatment landscape in breast cancer has evolved dramatically within the past several decades.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Prostate Cancer | Regimens | Drugs |
| Rare Cancers | Regimens | |
| Renal Cell Carcinoma | Regimens | Drugs |
| Skin Cancer | Regimens | Drugs |
| Urologic Cancers | Regimens | Drugs |
Cancer Therapy Advisor Articles
- Phase 2 Trial of Apatorsen for Metastatic Pancreatic Cancer Misses Primary Endpoint
- Standard Therapy for Anal Cancer May Not Affect Long-term Outcomes Among HIV Patients
- Effective Communication With Patients Is Critical for Improved Quality of Life, Lower Costs
- Tibetan Yoga May Improve Chemotherapy-related Fatigue
- Sequence of Sunitinib and Nephrectomy May Not Affect Progression-free Rate in mRCC